Relacorilant (CORT125134)

Relacorilant (CORT125134) is an antagonist of Glucagon Receptor and Glucocorticoid Receptor used in studies of Immune Signaling and GPCR Signaling and related signaling programs. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to cytokine-mediated signaling and inflammatory effector responses and receptor-driven second-messenger signaling and desensitization dynamics in endocrinology, immunology, and inflammation models.

By blocking Glucagon Receptor and Glucocorticoid Receptor, Relacorilant (CORT125134) can be used to examine cytokine-mediated signaling and inflammatory effector responses and receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In endocrinology, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Glucagon Receptor and Glucocorticoid Receptor
• Pathway perturbation studies connected to Immune Signaling and GPCR Signaling and related signaling programs
• Receptor-blockade and ligand-competition studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, Relacorilant (CORT125134) is appropriate when a defined chemical perturbant is needed to connect Glucagon Receptor and Glucocorticoid Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in endocrinology, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.